Will Host Second Annual Culinary Tour of Nations Luncheon for Poultry Production Customers
MADISON, NEW JERSEY January 19, 2015 – Merck Animal Health (known as MSD Animal Health outside the USA and Canada) today announced it will be a platinum sponsor of the International Production & Processing Expo in Atlanta, Georgia from January 27-29.
The International Production & Processing Expo (IPPE) is a collaboration of three shows: International Poultry Expo, International Feed Expo, and International Meat Expo – representing the entire chain of protein production and processing.
“Poultry producers today are under increasing pressure to achieve optimal performance from their flocks,” said Delair Bolis, Executive Director, Global Poultry Marketing, Merck Animal Health. “We are pleased to take part in the International Production & Processing Expo and offer poultry producers the opportunity to learn more about improving the health and performance of their flocks, and meeting their financial goals.”
Merck Animal Health will also host a Culinary Tour of Nations luncheon at the Expo. The luncheon will provide attendees the opportunity to meet poultry production personnel from many countries while enjoying poultry dishes from around the world. The company will also bestow a research sponsorship to the University of Georgia College of Veterinary Medicine during the event. The Culinary Tour of Nations luncheon will be held on January 28 at 12:00 PM in the Georgia World Conference Center and is by invitation only.
Merck Animal Health is also inviting a limited number of attendees to Step Up to Solutions by visiting the top level of its two-story booth, where they can have one-on-one discussions with experts in the poultry industry.
Attendees who are interested in attending the Culinary Tour of Nations event or Step Up to Solutions should contact their local Merck Animal Health sales representative or visit the Merck Animal Health booth at the Expo (Booth #A421).
For more information about the International Production & Processing Expo, visit http://www.ippexpo.org.
About Merck Animal Health
Today’s Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn and Twitter at @MerckAH.
Merck forward-Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially viable successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in MSD’s 2013 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).